Trials / Completed
CompletedNCT00832689
Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 17 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The study hypothesis is that chemotherapy of irinotecan and gemcitabine will improve local control of cancer and prolong survival in patients with inoperable biliary tract cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Irinotecan and Gemcitabine |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-02-01
- Completion
- 2010-03-01
- First posted
- 2009-01-30
- Last updated
- 2011-03-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00832689. Inclusion in this directory is not an endorsement.